Astrogliosis

Source: Wikipedia, the free encyclopedia.
Astrogliosis
Formation of reactive astrocytes after central nervous system (CNS) injury
Anatomical terminology

Astrogliosis (also known as astrocytosis or referred to as reactive astrogliosis) is an abnormal increase in the number of

astrocytes play critical roles in energy provision, regulation of blood flow, homeostasis of extracellular fluid, homeostasis of ions and transmitters, regulation of synapse function and synaptic remodeling.[1][2] Astrogliosis changes the molecular expression and morphology of astrocytes, in response to infection for example, in severe cases causing glial scar formation that may inhibit axon regeneration.[3][4]

Causes

Reactive astrogliosis is a spectrum of changes in

astrocytes that occur in response to all forms of CNS injury and disease. Changes due to reactive astrogliosis vary with the severity of the CNS insult along a graduated continuum of progressive alterations in molecular expression, progressive cellular hypertrophy, proliferation and scar formation.[3]

Insults to neurons in the central nervous system caused by infection, trauma, ischemia, stroke, recurring seizures, autoimmune responses, or other neurodegenerative diseases may cause reactive astrocytes.[2]

When the astrogliosis is pathological itself, instead of a normal response to a pathological problem, it is referred to as astrocytopathy.[5]

Functions and effects

Reactive astrocytes may benefit or harm surrounding neural and non-neural cells. They undergo a series of changes that may alter astrocyte activities through gain or loss of functions lending to neural protection and repair,

glial scarring, and regulation of CNS inflammation.[3]

Neural protection and repair

Proliferating reactive astrocytes are critical to scar formation and function to reduce the spread and persistence of inflammatory cells, to maintain the repair of the blood–brain barrier (BBB), to decrease tissue damage and lesion size, and to decrease neuronal loss and demyelination.[6][7]

Reactive astrocytes defend against oxidative stress through glutathione production and have the responsibility of protecting CNS cells from NH4+ toxicity.[3] They protect CNS cells and tissue through various methods,

blood brain barrier properties.[8]

They have also been shown to reduce

vasogenic edema after trauma, stroke, or obstructive hydrocephalus.[3]

Scar formation

Proliferating reactive scar-forming astrocytes are consistently found along borders between healthy tissues and pockets of damaged tissue and inflammatory cells. This is usually found after a rapid, locally triggered inflammatory response to acute traumatic injury in the spinal cord and brain. In its extreme form, reactive astrogliosis can lead to the appearance of newly proliferated astrocytes and scar formation in response to severe tissue damage or inflammation.

Molecular triggers that lead to this scar formation include

ependymal cell progenitors after injury or stroke. There are also multipotent progenitors in subependymal tissue that express glial fibrillary acidic protein (GFAP) and generate progeny cells that migrate towards sites of injury after trauma or stroke.[10]

Regulation of inflammation

Reactive astrocytes are related to the normal function of astrocytes. Astrocytes are involved in the complex regulation of CNS inflammation that is likely to be context-dependent and regulated by multimodal extra- and intracellular signaling events. They have the capacity to make different types of molecules with either pro- or anti-inflammatory potential in response to different types of stimulation. Astrocytes interact extensively with microglia and play a key role in CNS inflammation. Reactive astrocytes can then lead to abnormal function of astrocytes and affect their regulation and response to inflammation.[10][11]

Pertaining to anti-inflammatory effects, reactive scar-forming astrocytes help reduce the spread of inflammatory cells during locally initiated inflammatory responses to traumatic injury or during peripherally-initiated adaptive immune responses.[3][8] In regard to pro-inflammatory potential, certain molecules in astrocytes are associated with an increase in inflammation after traumatic injury.[3]

At early stages after insults, astrocytes not only activate inflammation, but also form potent cell migration barriers over time. These barriers mark areas where intense inflammation is needed and restrict the spread of inflammatory cells and infectious agents to nearby healthy tissue.[3][7][8] CNS injury responses have favored mechanisms that keep small injuries uninfected. Inhibition of the migration of inflammatory cells and infectious agents have led to the accidental byproduct of axon regeneration inhibition, owing to the redundancy between migration cues across cell types.[3][7]

Biological mechanisms

Changes resulting from astrogliosis are regulated in a context-specific manner by specific signaling events that have the potential to modify both the nature and degree of these changes. Under different conditions of stimulation,

neural plasticity
.

Reactive astrocytes in a rat brain stained against GFAP.

Signaling molecules

Few of the known signaling molecules and their effects are understood in the context of reactive astrocytes responding to different degrees of insult.

Upregulation of

Transporters and channels

The presence of astrocyte

AQP4, an astrocyte water channel, plays a crucial role in cytotoxic edema and aggravate outcome after stroke.[3]

Neurological pathologies

Loss or disturbance of functions normally performed by

trauma, stroke, multiple sclerosis, and others. Some of the examples are as follows:[3]

Reactive astrocytes may also be stimulated by specific signaling cascades to gain detrimental effects such as the following:[3][14]

  • Exacerbation of inflammation via cytokine production
  • Production and release of neurotoxic levels of reactive oxygen species
  • Release of potentially excitotoxic
    glutamate
  • The potential contribution to seizure genesis
  • Compromise of
    endothelial growth factor
    production
  • Cytotoxic
    AQP4
    overactivity
  • Potential for chronic
    astrocytes
    to contribute to chronic pain

Reactive astrocytes have the potential to promote neural toxicity via the generation cytotoxic molecules such as nitric oxide radicals and other reactive oxygen species,[7] which may damage nearby neurons. Reactive astrocytes may also promote secondary degeneration after CNS injury.[7]

Novel therapeutic techniques

Due to the destructive effects of astrogliosis, which include altered molecular expression, release of inflammatory factors, astrocyte proliferation and neuronal dysfunction, researchers are currently searching for new ways to treat astrogliosis and neurodegenerative diseases. Various studies have shown the role of astrocytes in diseases such as

Huntington's.[15] The inflammation caused by reactive astrogliosis augments many of these neurological diseases.[16]
Current studies are researching the possible benefits of inhibiting the inflammation caused by reactive gliosis in order to reduce its neurotoxic effects.

Anti-gliosis function of BB14

One specific drug candidate is BB14, which is a nerve growth factor-like peptide that acts as a

TrkA agonist.[15] BB14 was shown to reduce reactive astrogliosis following peripheral nerve injuries in rats by acting on DRG and PC12 cell differentiation.[15]
Although further research is needed, BB14 has the potential to treat a variety neurological diseases. Further research of neurotrophins could potentially lead to the development of a highly selective, potent, and small neurotrophin that targets reactive gliosis to alleviate some neurodegenerative diseases.

Regulatory function of TGFB

Interleukin 1. An anti-TGFβ antibody may potentially reduce GFAP upregulation after CNS injuries, promoting axonal regeneration.[2]

Ethidium bromide treatment

Injection of

macrophages unaffected.[2][4] This provides an environment conducive to axonal regeneration for about four days. After four days, CNS glia reinvade the area of injection and axonal regeneration is consequently inhibited.[2] This method has been shown to reduce glial scarring following CNS trauma.[4]

Metalloprotinease activity

Oligodendrocyte precursor cells and C6

Schwann cells. Consequently, increased metalloproteinase in the environment around axons may facilitate axonal regeneration via degradation of inhibitory molecules due to increased proteolytic activity.[2]

References